TFRC and cancer: Cellular fluorescence imaging and flow cytometry analyses confirmed that TfR aptamer-functionalized MSNs achieved markedly higher uptake across three cancer cell lines (MCF-7, A549, and HeLa), demonstrating both improved efficiency and selectivity [175].